BCL2 and cancer: Among the cancer-associated proteins whose expression is downregulated by small molecule BRD4 inhibitors are the oncogenic driver c-Myc [89,90], the anti-apoptotic Bcl2 [91], and cell cycle regulators such as the cyclin-dependent kinases [92].